Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Schweizer Monatsschrift Fur Zahnmedizin = Revue Mensuelle Suisse D'Odonto-Stomatologie = Rivista Mensile Svizzera Di Odontologia E Stomatologia|November 9, 2004
[Implant prosthesis rehabilitation after maxillofacial injuries--case report]Peter Kiener, Matthias Oetterli, Regina Mericske-Stern
Schweizer Monatsschrift Fur Zahnmedizin = Revue Mensuelle Suisse D'Odonto-Stomatologie = Rivista Mensile Svizzera Di Odontologia E Stomatologia|May 4, 2004
[Limits of total prostheses in resected patients. Case report]Peter Kiener, Matthias Oetterli, Regina Mericske-Stern
Schweizer Monatsschrift Fur Zahnmedizin = Revue Mensuelle Suisse D'Odonto-Stomatologie = Rivista Mensile Svizzera Di Odontologia E Stomatologia|November 25, 2003
[Prosthetic rehabilitation in ectodermal dysplasia. Case report]Peter Kiener, Matthias Oetterli, Regina Mericske-Stern
The International Journal of Oral & Maxillofacial Implants|October 17, 2002
A follow-up study of maxillary implants supporting an overdenture: clinical and radiographic resultsRegina Mericske-Stern, Matthias Oetterli, Peter Kiener, et al.
Antiviral Therapy|April 9, 2008
The prophylactic administration of a monoclonal antibody against human metapneumovirus attenuates viral disease and airways hyperresponsiveness in miceMarie-Eve Hamelin, Christian Couture, Melanie Sackett, et al.
Antiviral Research|July 13, 2010
Prophylactic and therapeutic benefits of a monoclonal antibody against the fusion protein of human metapneumovirus in a mouse modelMarie-Eve Hamelin, Constance Gagnon, Gregory A Prince, et al.
Acta Histochemica|August 12, 2014
Clock gene expression in different synovial cells of patients with rheumatoid arthritis and osteoarthritisTatjana Becker, Makiyeh Tohidast-Akrad, Susanne Humpeler, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 1, 2007
Strictly target cell-dependent activation of T cells by bispecific single-chain antibody constructs of the BiTE classKlaus Brischwein, Larissa Parr, Stefan Pflanz, et al.
British Journal of Haematology|September 10, 2011
A glycoengineered anti-CD19 antibody with potent antibody-dependent cellular cytotoxicity activity in vitro and lymphoma growth inhibition in vivoElizabeth Ward, Nanette Mittereder, Ellen Kuta, et al.
Leukemia Research|October 7, 2008
Combination of rituximab with blinatumomab (MT103/MEDI-538), a T cell-engaging CD19-/CD3-bispecific antibody, for highly efficient lysis of human B lymphoma cellsSandrine d'Argouges, Sandra Wissing, Christian Brandl, et al.
Pageof 2